Gilead Builds Up Trodelvy Data In TNBC Ahead Of Competition

 
• By Alaric DeArment
  
Doctor with Mammography - Image
Gilead presented data on Trodelvy in triple-negative breast cancer at the ESMO meeting on 16 September • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category